$GILD Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in GILEAD SCIENCES INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in GILEAD SCIENCES INC. Get notifications about new insider transactions in GILEAD SCIENCES INC for free.
Page: < prev 1 ... 33 34 35 36 37 38 39 40 41 ... 46 next >
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Oct 25 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 69.46 | 533 | 37,022 | 64,523 | 65.1 K to 64.5 K (-0.82 %) |
| Oct 25 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 69.47 | 2,543 | 176,662 | 65,056 | 67.6 K to 65.1 K (-3.76 %) |
| Oct 25 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 69.49 | 500 | 34,745 | 67,599 | 68.1 K to 67.6 K (-0.73 %) |
| Oct 25 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Sell | S | 69.50 | 300 | 20,850 | 68,099 | 68.4 K to 68.1 K (-0.44 %) |
| Oct 25 2006 | GILD | GILEAD SCIENCES IN ... | LEE WILLIAM A | SVP, Research | Buy | M | 7.40 | 30,000 | 221,955 | 68,399 | 38.4 K to 68.4 K (+78.13 %) |
| Oct 20 2006 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Option Exercise | M | 3.13 | 56,000 | 175,000 | 0 | |
| Oct 20 2006 | GILD | GILEAD SCIENCES IN ... | MOORE GORDON EARLE | Director | Buy | M | 3.13 | 56,000 | 175,000 | 458,648 | 402.6 K to 458.6 K (+13.91 %) |
| Oct 16 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.60 | 1,200 | 16,323 | 58,662 | |
| Oct 16 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 67.00 | 1,200 | 80,400 | 24,395 | 25.6 K to 24.4 K (-4.69 %) |
| Oct 16 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 13.60 | 1,200 | 16,323 | 25,595 | 24.4 K to 25.6 K (+4.92 %) |
| Oct 12 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 2.86 | 35,000 | 100,079 | 385,392 | |
| Oct 12 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 64.53 | 5,000 | 322,644 | 737,629 | 742.6 K to 737.6 K (-0.67 %) |
| Oct 12 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 64.49 | 5,000 | 322,471 | 742,629 | 747.6 K to 742.6 K (-0.67 %) |
| Oct 12 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 64.50 | 5,000 | 322,505 | 747,629 | 752.6 K to 747.6 K (-0.66 %) |
| Oct 12 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 64.61 | 3,100 | 200,293 | 752,629 | 755.7 K to 752.6 K (-0.41 %) |
| Oct 12 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 64.53 | 5,000 | 322,664 | 755,729 | 760.7 K to 755.7 K (-0.66 %) |
| Oct 12 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 64.52 | 5,000 | 322,578 | 760,729 | 765.7 K to 760.7 K (-0.65 %) |
| Oct 12 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 64.45 | 3,200 | 206,244 | 765,729 | 768.9 K to 765.7 K (-0.42 %) |
| Oct 12 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 64.40 | 3,700 | 238,280 | 768,929 | 772.6 K to 768.9 K (-0.48 %) |
| Oct 12 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 2.86 | 35,000 | 100,079 | 772,629 | 737.6 K to 772.6 K (+4.74 %) |
| Oct 04 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.60 | 3,550 | 48,289 | 59,862 | |
| Oct 04 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.35 | 850 | 54,698 | 24,395 | 25.2 K to 24.4 K (-3.37 %) |
| Oct 04 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.50 | 300 | 19,350 | 25,245 | 25.5 K to 25.2 K (-1.17 %) |
| Oct 04 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.90 | 1,000 | 64,900 | 25,545 | 26.5 K to 25.5 K (-3.77 %) |
| Oct 04 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 65.00 | 600 | 39,000 | 26,545 | 27.1 K to 26.5 K (-2.21 %) |
| Oct 04 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 65.14 | 100 | 6,514 | 27,145 | 27.2 K to 27.1 K (-0.37 %) |
| Oct 04 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 65.15 | 100 | 6,515 | 27,245 | 27.3 K to 27.2 K (-0.37 %) |
| Oct 04 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 65.16 | 100 | 6,516 | 27,345 | 27.4 K to 27.3 K (-0.36 %) |
| Oct 04 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 65.17 | 200 | 13,034 | 27,445 | 27.6 K to 27.4 K (-0.72 %) |
| Oct 04 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 65.25 | 300 | 19,575 | 27,645 | 27.9 K to 27.6 K (-1.07 %) |
| Oct 04 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 13.60 | 3,550 | 48,289 | 27,945 | 24.4 K to 27.9 K (+14.55 %) |
| Sep 15 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Option Exercise | M | 4.78 | 6,500 | 31,078 | 62,000 | |
| Sep 15 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 63.70 | 990 | 63,063 | 9,000 | 10 K to 9 K (-9.91 %) |
| Sep 15 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 63.69 | 2,100 | 133,749 | 9,990 | 12.1 K to 10 K (-17.37 %) |
| Sep 15 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 63.68 | 709 | 45,149 | 12,090 | 12.8 K to 12.1 K (-5.54 %) |
| Sep 15 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 63.33 | 191 | 12,096 | 12,799 | 13 K to 12.8 K (-1.47 %) |
| Sep 15 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 63.32 | 300 | 18,996 | 12,990 | 13.3 K to 13 K (-2.26 %) |
| Sep 15 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 63.31 | 1,186 | 75,086 | 13,290 | 14.5 K to 13.3 K (-8.19 %) |
| Sep 15 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 63.28 | 14 | 886 | 14,476 | 14.5 K to 14.5 K (-0.10 %) |
| Sep 15 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Sell | S | 63.25 | 1,010 | 63,883 | 14,490 | 15.5 K to 14.5 K (-6.52 %) |
| Sep 15 2006 | GILD | GILEAD SCIENCES IN ... | BERG PAUL | Director | Buy | M | 4.78 | 6,500 | 31,078 | 15,500 | 9 K to 15.5 K (+72.22 %) |
| Sep 29 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Option Exercise | M | 13.60 | 1,112 | 15,126 | 63,412 | |
| Sep 29 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 67.00 | 1,288 | 86,296 | 24,395 | 25.7 K to 24.4 K (-5.01 %) |
| Sep 29 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 67.00 | 1,112 | 74,504 | 25,683 | 26.8 K to 25.7 K (-4.15 %) |
| Sep 29 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Buy | M | 13.60 | 1,112 | 15,126 | 26,795 | 25.7 K to 26.8 K (+4.33 %) |
| Sep 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Option Exercise | M | 2.86 | 35,000 | 100,079 | 420,392 | |
| Sep 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 62.99 | 7,500 | 472,451 | 736,909 | 744.4 K to 736.9 K (-1.01 %) |
| Sep 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 62.89 | 9,000 | 566,027 | 744,409 | 753.4 K to 744.4 K (-1.19 %) |
| Sep 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 62.76 | 3,500 | 219,660 | 753,409 | 756.9 K to 753.4 K (-0.46 %) |
| Sep 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 62.75 | 7,500 | 470,606 | 756,909 | 764.4 K to 756.9 K (-0.98 %) |
| Sep 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Sell | S | 62.84 | 7,500 | 471,293 | 764,409 | 771.9 K to 764.4 K (-0.97 %) |
| Sep 14 2006 | GILD | GILEAD SCIENCES IN ... | MARTIN JOHN C | President and CEO | Buy | M | 2.86 | 35,000 | 100,079 | 771,909 | 736.9 K to 771.9 K (+4.75 %) |
| Sep 12 2006 | GILD | GILEAD SCIENCES IN ... | Montgomery Alan Bruce | SVP, Respiratory Th ... | Option Exercise | A | 63.69 | 70,000 | 4,458,300 | 70,000 | |
| Sep 12 2006 | GILD | GILEAD SCIENCES IN ... | Montgomery Alan Bruce | SVP, Respiratory Th ... | Grant | A | 0.00 | 14,000 | 0 | 14,280 | 280 to 14.3 K (+5,000.00 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.91 | 100 | 6,391 | 24,936 | 25 K to 24.9 K (-0.40 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.85 | 100 | 6,385 | 25,036 | 25.1 K to 25 K (-0.40 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.84 | 100 | 6,384 | 25,136 | 25.2 K to 25.1 K (-0.40 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.80 | 100 | 6,380 | 25,236 | 25.3 K to 25.2 K (-0.39 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.79 | 100 | 6,379 | 25,336 | 25.4 K to 25.3 K (-0.39 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.75 | 100 | 6,375 | 25,436 | 25.5 K to 25.4 K (-0.39 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.70 | 546 | 34,780 | 25,536 | 26.1 K to 25.5 K (-2.09 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.69 | 100 | 6,369 | 26,082 | 26.2 K to 26.1 K (-0.38 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.68 | 100 | 6,368 | 26,182 | 26.3 K to 26.2 K (-0.38 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.66 | 354 | 22,536 | 26,282 | 26.6 K to 26.3 K (-1.33 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.64 | 250 | 15,910 | 26,636 | 26.9 K to 26.6 K (-0.93 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.56 | 100 | 6,356 | 26,886 | 27 K to 26.9 K (-0.37 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.54 | 100 | 6,354 | 26,986 | 27.1 K to 27 K (-0.37 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.51 | 100 | 6,351 | 27,086 | 27.2 K to 27.1 K (-0.37 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.50 | 100 | 6,350 | 27,186 | 27.3 K to 27.2 K (-0.37 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.49 | 100 | 6,349 | 27,286 | 27.4 K to 27.3 K (-0.37 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.48 | 100 | 6,348 | 27,386 | 27.5 K to 27.4 K (-0.36 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.45 | 100 | 6,345 | 27,486 | 27.6 K to 27.5 K (-0.36 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.41 | 200 | 12,682 | 27,586 | 27.8 K to 27.6 K (-0.72 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.40 | 100 | 6,340 | 27,786 | 27.9 K to 27.8 K (-0.36 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.38 | 100 | 6,338 | 27,886 | 28 K to 27.9 K (-0.36 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.35 | 200 | 12,670 | 27,986 | 28.2 K to 28 K (-0.71 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.32 | 100 | 6,332 | 28,186 | 28.3 K to 28.2 K (-0.35 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.19 | 100 | 6,319 | 28,286 | 28.4 K to 28.3 K (-0.35 %) |
| Sep 06 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 63.13 | 100 | 6,313 | 28,386 | 28.5 K to 28.4 K (-0.35 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.68 | 932 | 59,350 | 12,019 | 13 K to 12 K (-7.20 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.69 | 500 | 31,845 | 13,051 | 13.6 K to 13.1 K (-3.69 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.72 | 100 | 6,372 | 13,551 | 13.7 K to 13.6 K (-0.73 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.89 | 100 | 6,389 | 13,651 | 13.8 K to 13.7 K (-0.73 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.05 | 232 | 14,860 | 28,486 | 28.7 K to 28.5 K (-0.81 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.06 | 768 | 49,198 | 28,718 | 29.5 K to 28.7 K (-2.60 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.10 | 1,000 | 64,100 | 29,486 | 30.5 K to 29.5 K (-3.28 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.20 | 1,000 | 64,200 | 30,486 | 31.5 K to 30.5 K (-3.18 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | Alton Gregg H | SVP, General Counse ... | Sell | S | 64.83 | 550 | 35,657 | 31,486 | 32 K to 31.5 K (-1.72 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | M | 7.40 | 26,000 | 192,361 | 0 | |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Option Exercise | M | 9.81 | 24,000 | 235,440 | 30,000 | |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.94 | 298 | 19,054 | 13,751 | 14 K to 13.8 K (-2.12 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.94 | 202 | 12,916 | 14,049 | 14.3 K to 14 K (-1.42 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.88 | 500 | 31,940 | 14,251 | 14.8 K to 14.3 K (-3.39 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.87 | 800 | 51,096 | 14,751 | 15.6 K to 14.8 K (-5.14 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.86 | 1,500 | 95,790 | 15,551 | 17.1 K to 15.6 K (-8.80 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.85 | 500 | 31,925 | 17,051 | 17.6 K to 17.1 K (-2.85 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.81 | 6,200 | 395,622 | 17,551 | 23.8 K to 17.6 K (-26.10 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.78 | 300 | 19,134 | 23,751 | 24.1 K to 23.8 K (-1.25 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.77 | 400 | 25,508 | 24,051 | 24.5 K to 24.1 K (-1.64 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.76 | 2,100 | 133,896 | 24,451 | 26.6 K to 24.5 K (-7.91 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.75 | 400 | 25,500 | 26,551 | 27 K to 26.6 K (-1.48 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.74 | 500 | 31,870 | 26,951 | 27.5 K to 27 K (-1.82 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.73 | 1,200 | 76,476 | 27,451 | 28.7 K to 27.5 K (-4.19 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.71 | 3,100 | 197,501 | 28,651 | 31.8 K to 28.7 K (-9.76 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.70 | 1,300 | 82,810 | 31,751 | 33.1 K to 31.8 K (-3.93 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.69 | 791 | 50,379 | 33,051 | 33.8 K to 33.1 K (-2.34 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.68 | 200 | 12,736 | 33,842 | 34 K to 33.8 K (-0.59 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.67 | 300 | 19,101 | 34,042 | 34.3 K to 34 K (-0.87 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.66 | 4,806 | 305,950 | 34,342 | 39.1 K to 34.3 K (-12.28 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.65 | 901 | 57,349 | 39,148 | 40 K to 39.1 K (-2.25 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.64 | 4,684 | 298,090 | 40,049 | 44.7 K to 40 K (-10.47 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.63 | 1,450 | 92,264 | 44,733 | 46.2 K to 44.7 K (-3.14 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.62 | 8,550 | 543,951 | 46,183 | 54.7 K to 46.2 K (-15.62 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.61 | 8,618 | 548,191 | 54,733 | 63.4 K to 54.7 K (-13.60 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Sell | S | 63.60 | 200 | 12,720 | 63,351 | 63.6 K to 63.4 K (-0.31 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Buy | M | 7.40 | 26,000 | 192,361 | 63,551 | 37.6 K to 63.6 K (+69.24 %) |
| Aug 18 2006 | GILD | GILEAD SCIENCES IN ... | TOOLE JOHN J | SVP, Clinical Resea ... | Buy | M | 9.81 | 24,000 | 235,440 | 37,551 | 13.6 K to 37.6 K (+177.11 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 62.89 | 96 | 6,037 | 65,000 | 65.1 K to 65 K (-0.15 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 62.88 | 2,737 | 172,103 | 65,096 | 67.8 K to 65.1 K (-4.03 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 62.87 | 862 | 54,194 | 67,833 | 68.7 K to 67.8 K (-1.25 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 62.86 | 1,305 | 82,032 | 68,695 | 70 K to 68.7 K (-1.86 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 62.75 | 5,000 | 313,750 | 70,000 | 75 K to 70 K (-6.67 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 62.18 | 400 | 24,872 | 75,000 | 75.4 K to 75 K (-0.53 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 62.12 | 1,500 | 93,180 | 75,400 | 76.9 K to 75.4 K (-1.95 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 62.10 | 917 | 56,946 | 76,900 | 77.8 K to 76.9 K (-1.18 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 5.13 | 8,400 | 43,116 | 63,600 | |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Option Exercise | M | 4.78 | 31,600 | 151,089 | 0 | |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 62.09 | 600 | 37,254 | 77,817 | 78.4 K to 77.8 K (-0.77 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 62.08 | 1,083 | 67,233 | 78,417 | 79.5 K to 78.4 K (-1.36 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 62.07 | 500 | 31,035 | 79,500 | 80 K to 79.5 K (-0.62 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.79 | 500 | 30,895 | 80,000 | 80.5 K to 80 K (-0.62 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.78 | 200 | 12,356 | 80,500 | 80.7 K to 80.5 K (-0.25 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.76 | 200 | 12,352 | 80,700 | 80.9 K to 80.7 K (-0.25 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.75 | 200 | 12,350 | 80,900 | 81.1 K to 80.9 K (-0.25 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.74 | 100 | 6,174 | 81,100 | 81.2 K to 81.1 K (-0.12 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.72 | 500 | 30,860 | 81,200 | 81.7 K to 81.2 K (-0.61 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.70 | 700 | 43,190 | 81,700 | 82.4 K to 81.7 K (-0.85 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.69 | 600 | 37,014 | 82,400 | 83 K to 82.4 K (-0.72 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.68 | 1,200 | 74,016 | 83,000 | 84.2 K to 83 K (-1.43 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.67 | 1,008 | 62,163 | 84,200 | 85.2 K to 84.2 K (-1.18 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.66 | 600 | 36,996 | 85,208 | 85.8 K to 85.2 K (-0.70 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.65 | 1,800 | 110,970 | 85,808 | 87.6 K to 85.8 K (-2.05 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.64 | 1,200 | 73,968 | 87,608 | 88.8 K to 87.6 K (-1.35 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.62 | 3,200 | 197,184 | 88,808 | 92 K to 88.8 K (-3.48 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.61 | 1,400 | 86,254 | 92,008 | 93.4 K to 92 K (-1.50 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.60 | 800 | 49,280 | 93,408 | 94.2 K to 93.4 K (-0.85 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.59 | 500 | 30,795 | 94,208 | 94.7 K to 94.2 K (-0.53 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.57 | 100 | 6,157 | 94,708 | 94.8 K to 94.7 K (-0.11 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Sell | S | 61.56 | 192 | 11,820 | 94,808 | 95 K to 94.8 K (-0.20 %) |
| Aug 11 2006 | GILD | GILEAD SCIENCES IN ... | DENNY JAMES M | Director | Buy | M | 5.13 | 8,400 | 43,116 | 95,000 | 86.6 K to 95 K (+9.70 %) |